|
KNTC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.05849999771013E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96070000235693E-08 |
| Normal-vs-Stage2 |
1.895820E-01 |
| Normal-vs-Stage3 |
3.38230000007655E-07 |
| Normal-vs-Stage4 |
9.86919999945712E-07 |
| Stage1-vs-Stage2 |
2.59970000004994E-06 |
| Stage1-vs-Stage3 |
9.678400E-01 |
| Stage1-vs-Stage4 |
7.255200E-01 |
| Stage2-vs-Stage3 |
5.9894999999921E-05 |
| Stage2-vs-Stage4 |
1.614690E-04 |
| Stage3-vs-Stage4 |
7.254200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.92519996903229E-09 |
| Normal-vs-AfricanAmerican |
2.362200E-03 |
| Normal-vs-Asian |
3.84729999969302E-07 |
| Caucasian-vs-AfricanAmerican |
6.716200E-01 |
| Caucasian-vs-Asian |
7.467600E-01 |
| AfricanAmerican-vs-Asian |
8.170800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44900000004422E-06 |
| Normal-vs-Female |
3.02170000132662E-08 |
| Male-vs-Female |
2.106600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.16619996887368E-09 |
| Normal-vs-Age(41-60Yrs) |
2.78509999995791E-06 |
| Normal-vs-Age(61-80Yrs) |
4.42219999999827E-05 |
| Normal-vs-Age(81-100Yrs) |
4.326000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.509900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.267600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.250800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.202200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.974800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.977400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.444050E-01 |
| Classical-VS-Follicular |
1.81754611361384E-12 |
| Classical-VS-Other |
1.928040E-01 |
| Classical-VS-Normal |
9.86140058500951E-11 |
| Tall-VS-Follicular |
2.09829997821487E-09 |
| Tall-VS-Other |
3.039600E-02 |
| Tall-VS-Normal |
6.35010000138436E-09 |
| Follicular-VS-Other |
2.695600E-01 |
| Follicular-VS-Normal |
2.557200E-01 |
| Other-VS-Normal |
1.384980E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.25380000000009E-05 |
| Normal-vs-N1 |
7.0272999974641E-08 |
| N0-vs-N1 |
4.644700E-03 |
|
|
